We Can Help.

Contact us today for a complimentary consultation with a qualified attorney near you.

 
print page Bookmark and Share increase font size

Contact Us Today

Use this form to request a free consultation with a qualified attorney near you.

ATTORNEY ADVERTISING -

Your privacy is important to us. Any information submitted to this form is guaranteed safe, secure, and private.

Merck says Vioxx heart effects a "class effect"

February 16, 2005

Researchers at Merck & Co., the makers of now withdrawn drug Vioxx, are saying the cardiovascular effects resulting in Vioxx's removal from the market are part of a "class effect."

Vioxx was recalled after links to increased risk of heart attacks and stroke were discovered, creating safety concerns over the entire class of drugs Vioxx belongs to, called COX-2 inhibitors. The FDA is currently reviewing Pfizer Inc.'s Celebrex and Bextra, the only two remaining COX-2 drugs on the market since the Vioxx recall.

The Merck researchers were addressing a panel of experts convened by the FDA to evaluate the safety of COX-2 drugs. Merck said in a statement that the class effect might extend beyond the COX-2 inhibitors and affect many older non-steroidal anti-inflammatory drugs (NSAIDs) as well. NSAIDs include common treatments like ibuprofen - the ingredient found in popular over-the-counter drugs Motrin and Advil.

For more information on Vioxx, please contact us to confer with a Vioxx Lawyer and learn your legal rights and options.

 

More Recent Defective Drug News

Contact a News Recall Lawyer